Firefly Biologics
Daniel Kaplan is a seasoned scientific leader with extensive experience in the biopharmaceutical industry. Currently serving as the Chief Scientific Officer at Firefly Bio since October 2025, Kaplan previously held the same title at NGM Biopharmaceuticals from November 2008 to October 2025, where responsibilities included roles in immuno-oncology and translational science. Academic foundations were established with a Ph.D. in Pharmacology from Duke University, complemented by postdoctoral training at Stanford University in Chemical and Systems Biology and Developmental Biology. Kaplan also holds a certificate in Artificial Intelligence in Pharma and Biotech from MIT Sloan School of Management, along with a B.S. in Biochemistry and Cell Biology from UC San Diego.
This person is not in the org chart
This person is not in any teams
This person is not in any offices